Danesi, Romano <br/><br/>
Importance of preclinical investigations of the integration of capecitabine into polychemotherapy regimens.  [electronic resource] 

 -  Clinical colorectal cancer  Jan 2005 
 - 344 p.  digital 
<br/><br/> Publication Type: Journal Article; Comment 
<br/><br/><label>ISSN: </label>1533-0028 
<br/><br/><label>Standard No.: </label>10.1016/s1533-0028(11)70138-4  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Antineoplastic Combined Chemotherapy Protocols--pharmacology<br/>Camptothecin--analogs & derivatives<br/>Capecitabine<br/>Cell Line, Tumor<br/>Colonic Neoplasms--drug therapy<br/>Deoxycytidine--analogs & derivatives<br/>Dose-Response Relationship, Drug<br/>Drug Synergism<br/>Female<br/>Fluorouracil--pharmacology<br/>Irinotecan<br/>Maximum Tolerated Dose<br/>Mice<br/>Mice, Nude<br/>Neoplasm Transplantation<br/>Quinazolines--pharmacology<br/>Thiophenes--pharmacology